Sort   by:  
 Page size 
TranscriptomicsChIP-chip by array of yeast strains BY and RM after TSA treatment and recovery using anti-H3K14ac polyclonal antibody to investigate the stability of chromatin acetylation epi-polymorphisms
Strains BY and RM were cultivated with high concentrations of Trichostatin-A (TSA) and then let recover for >20 generations before re-profiling H3K14ac by ChIP as in Nagarajan et al. 2010 PLoS Genetics
ORGANISM(S): Saccharomyces cerevisiae 
2012-09-21 | E-MTAB-1025 | biostudies-arrayexpress
TranscriptomicsGenetic control of yeast chromatin acetylation epi-polymorphisms
Genetic control of yeast chromatin acetylation epi-polymorphisms
ORGANISM(S): Saccharomyces cerevisiae 
2012-09-21 | E-MTAB-575 | biostudies-arrayexpress
UnknownLong-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.
Not available
S-EPMC9857594 | biostudies-literature
UnknownEffect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC8941448 | biostudies-literature
UnknownIntravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.
Not available
S-EPMC10600726 | biostudies-literature
UnknownEffect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC10326520 | biostudies-literature
UnknownSimvastatin in Critically Ill Patients with Covid-19.
Not available
S-EPMC10755839 | biostudies-literature
Sort   by:  
 Page size